Related references
Note: Only part of the references are listed.Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Lindsay A. Becker et al.
NATURE (2017)
Association of alcohol use disorders with amyotrophic lateral sclerosis: a Swedish national cohort study
J. Ji et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter
I. Gijselinck et al.
MOLECULAR PSYCHIATRY (2016)
ALS BIOMARKERS FOR THERAPY DEVELOPMENT: STATE OF THE FIELD AND FUTURE DIRECTIONS
Michael Benatar et al.
MUSCLE & NERVE (2016)
The molecular hallmarks of epigenetic control
C. David Allis et al.
NATURE REVIEWS GENETICS (2016)
Association between alcohol consumption and amyotrophic lateral sclerosis: a meta-analysis of five observational studies
Meng E et al.
NEUROLOGICAL SCIENCES (2016)
DNA methylation in Huntington's disease: Implications for transgenerational effects
Elizabeth A. Thomas
NEUROSCIENCE LETTERS (2016)
The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients
Zhengrui Xi et al.
ACTA NEUROPATHOLOGICA (2015)
Global changes in DNA methylation in Alzheimer's disease peripheral blood mononuclear cells
Andrea Di Francesco et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Role of 5-hydroxymethylcytosine in neurodegeneration
Shariq I. Sherwani et al.
GENE (2015)
Epidemiology and molecular mechanism of frontotemporal lobar degeneration/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72
Hiroyuki Ishiura et al.
JOURNAL OF NEUROGENETICS (2015)
RNA-mediated epigenetic regulation of gene expression
Daniel Holoch et al.
NATURE REVIEWS GENETICS (2015)
The distinct genetic pattern of ALS in Turkey and novel mutations
Aslihan Ozoguz et al.
NEUROBIOLOGY OF AGING (2015)
Alterations in global DNA methylation and hydroxymethylation are not detected in Alzheimer's disease
T. Lashley et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier
Jenny Russ et al.
ACTA NEUROPATHOLOGICA (2015)
Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS
Mai Yamakawa et al.
HUMAN MOLECULAR GENETICS (2015)
Amyotrophic Lateral Sclerosis Genetic Studies: From Genome-wide Association Mapping to Genome Sequencing
Ji He et al.
NEUROSCIENTIST (2015)
Diverse Epigenetic Mechanisms of Human Disease
Emily Brookes et al.
ANNUAL REVIEW OF GENETICS, VOL 48 (2014)
Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients
Veronique V. Belzil et al.
BRAIN RESEARCH (2014)
Trinucleotide expansion in disease: why is there a length threshold?
Do-Yup Lee et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Epidemiological evidence that physical activity is not a risk factor for ALS
Bello Hamidou et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)
5-Hydroxymethylcytosine: A stable or transient DNA modification?
Maria A. Hahn et al.
GENOMICS (2014)
Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?
Kevin Talbot
JOURNAL OF ANATOMY (2014)
Prior medical conditions and the risk of amyotrophic lateral sclerosis
Meinie Seelen et al.
JOURNAL OF NEUROLOGY (2014)
Profilin 1 Associates with Stress Granules and ALS-Linked Mutations Alter Stress Granule Dynamics
Matthew D. Figley et al.
JOURNAL OF NEUROSCIENCE (2014)
Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study
Vincenzo Libri et al.
LANCET (2014)
State of play in amyotrophic lateral sclerosis genetics
Alan E. Renton et al.
NATURE NEUROSCIENCE (2014)
Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain
Daniel Condliffe et al.
NEUROBIOLOGY OF AGING (2014)
Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain
Natacha Coppieters et al.
NEUROBIOLOGY OF AGING (2014)
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers
Marka Van Blitterswijk et al.
NEUROBIOLOGY OF AGING (2014)
Epigenetics of discordant monozygotic twins: implications for disease
Juan E. Castillo-Fernandez et al.
GENOME MEDICINE (2014)
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset
Lucio Tremolizzo et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
Koji Abe et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Hypermethylation of the CpG Island Near the G4C2 Repeat in ALS with a C9orf72 Expansion
Zhengrui Xi et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: Pooled results from 5 cohort studies
Kathryn C. Fitzgerald et al.
ANNALS OF NEUROLOGY (2013)
Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
Jenny S. Henkel et al.
EMBO MOLECULAR MEDICINE (2013)
Lifetime physical activity and the risk of amyotrophic lateral sclerosis
Mark H. B. Huisman et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients
Leonidas Chouliaras et al.
NEUROBIOLOGY OF AGING (2013)
Epigenetic Mechanisms of Neurodegeneration in Huntington's Disease
Junghee Lee et al.
NEUROTHERAPEUTICS (2013)
Aberrant Regulation of DNA Methylation in Amyotrophic Lateral Sclerosis: A New Target of Disease Mechanisms
Lee J. Martin et al.
NEUROTHERAPEUTICS (2013)
5-hydroxymethylcytosine and its potential roles in development and cancer
Gerd P. Pfeifer et al.
EPIGENETICS & CHROMATIN (2013)
Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis
D. Michal Freedman et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
Smoking, Alcohol Consumption, and the Risk of Amyotrophic Lateral Sclerosis: A Population-based Study
Sonja W. de Jong et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
FXN methylation predicts expression and clinical outcome in Friedreich ataxia
Marguerite V. Evans-Galea et al.
ANNALS OF NEUROLOGY (2012)
Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications
Jose Miguel Laffita-Mesa et al.
HUMAN GENETICS (2012)
Friedreich Ataxia: New Pathways
Massimo Pandolfo
JOURNAL OF CHILD NEUROLOGY (2012)
Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early age
Peter Mattsson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
ATXN2 and Its Neighbouring Gene SH2B3 Are Associated with Increased ALS Risk in the Turkish Population
Suna Lahut et al.
PLOS ONE (2012)
Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis
Claudia Figueroa-Romero et al.
PLOS ONE (2012)
Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation
Ian R. A. Mackenzie et al.
ACTA NEUROPATHOLOGICA (2011)
Advances in Epigenetics and Epigenomics for Neurodegenerative Diseases
Irfan A. Qureshi et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis
Young-Eun Yoo et al.
EXPERIMENTAL NEUROLOGY (2011)
Ataxin-2 repeat-length variation and neurodegeneration
Owen A. Ross et al.
HUMAN MOLECULAR GENETICS (2011)
Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation
Barry A. Chestnut et al.
JOURNAL OF NEUROSCIENCE (2011)
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
Han-Xiang Deng et al.
NATURE (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton et al.
NEURON (2011)
The Global DNA Methylation Surrogate LINE-1 Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma
Fumiharu Ohka et al.
PLOS ONE (2011)
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Andrew C. Elden et al.
NATURE (2010)
Dietary Supplementation with S-Adenosyl Methionine Delays the Onset of Motor Neuron Pathology in a Murine Model of Amyotrophic Lateral Sclerosis
James Suchy et al.
NEUROMOLECULAR MEDICINE (2010)
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice
Steven J. Del Signore et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Smoking may be considered an established risk factor for sporadic ALS
Carmel Armon
NEUROLOGY (2009)
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Caroline Vance et al.
SCIENCE (2009)
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
T. J. Kwiatkowski et al.
SCIENCE (2009)
Methionine metabolism and liver disease
Jose M. Mato et al.
ANNUAL REVIEW OF NUTRITION (2008)
DNA methylation landscapes: provocative insights from epigenomics
Miho M. Suzuki et al.
NATURE REVIEWS GENETICS (2008)
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
Jemeen Sreedharan et al.
SCIENCE (2008)
The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues
Sahar Al-Mahdawi et al.
HUMAN MOLECULAR GENETICS (2008)
DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients
I. Castaldo et al.
JOURNAL OF MEDICAL GENETICS (2008)
DAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1
Ismael Al-Ramahi et al.
PLOS GENETICS (2007)
Molecular mechanisms of alcohol-mediated carcinogenesis
Helmut K. Seitz et al.
NATURE REVIEWS CANCER (2007)
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Tetsuaki Arai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice
H Ryu et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Can ataxin-2 be down-regulated by allele-specific de novo DNA methylation in SCA2 patients?
PO Bauer et al.
MEDICAL HYPOTHESES (2004)
Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy
R Frisch et al.
MOLECULAR GENETICS AND METABOLISM (2001)
Share Paper
